Ozanimod for Pregnant Women with Multiple Sclerosis
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Sex
- Female
- Study type
- Observational
- Participants needed
- 1,182 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
This trial is looking for pregnant women diagnosed with multiple sclerosis. It aims to gather information on the effects of a medication called ozanimod during pregnancy and how it affects mothers and their babies.
You may be able to join if
- I have been diagnosed with multiple sclerosis.
- I am currently or recently pregnant.
- I live in the United States, Canada, or Germany.
You may not be able to join if
- I have been exposed to other S1P therapies during the first trimester.
- I have used cladribine during the first trimester.
- I have used mitoxantrone during the first trimester.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to provide information on maternal, fetal, and infant outcomes following exposure of ozanimod during pregnancy so that participants and physicians can weigh the benefits and risks of exposure to the pharmaceutical during pregnancy and make informed treatment decisions.
Loading trial locations…
BMS Study Connect Contact Center www.BMSStudyConnect.com
855-907-3286
CONTACT
First line of the email MUST contain the NCT# and Site #.
CONTACT